Key result
Dysregulated adipokines drive the development of cardiometabolic diseases including obesity, diabetes, and CVD.
Why the study?
Dysregulated adipokines are implicated in metabolic and cardiovascular diseases, motivating an overview of their role in crosstalk between adipose tissues and other organs.
Understanding the endocrine functions of adipose tissue and its secreted adipokines highlights potential novel therapeutic targets for managing cardiometabolic diseases.
Supports adipokine modulation as a research target in cardiometabolic disease; leaves open clinical translation pending prospective trials.
Adipose tissue was previously regarded as a dormant organ for lipid storage until the identification of adiponectin and leptin in the early 1990s. This revelation unveiled the dynamic endocrine function of adipose tissue, which has expanded further. Adipose tissue has emerged in recent decades as a multifunctional organ that plays a significant role in energy metabolism and homeostasis. Currently, it is evident that adipose tissue primarily performs its function by secreting a diverse array of signaling molecules known as adipokines. Apart from their pivotal function in energy expenditure and metabolism regulation, these adipokines exert significant influence over a multitude of biological processes, including but not limited to inflammation, thermoregulation, immune response, vascular function, and insulin sensitivity. Adipokines are pivotal in regulating numerous biological processes within adipose tissue and facilitating communication between adipose tissue and various organs, including the brain, gut, pancreas, endothelial cells, liver, muscle, and more. Dysregulated adipokines have been implicated in several metabolic diseases, like obesity and diabetes, as well as cardiovascular diseases. In this article, we attempted to describe the significance of adipokines in developing metabolic and cardiovascular diseases and highlight their role in the crosstalk between adipose tissues and other tissues and organs.
No takes yet. Share an insight, caveat, or question.
Jouy et al. (2024) conducted a review in Cardiometabolic diseases. Adipokines was evaluated. Dysregulated adipokines are implicated in the development of metabolic diseases such as obesity and diabetes, as well as cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: